Medison introduces new breast probe (it's nice and long)

Article

Ultrasound vendor Medison America has introduced a new accessory for its Voluson 530D 3-D ultrasound system, a breast probe that will allow clinicians to visualize lesions, tumors, and other abnormalities as 3-D shapes. The probe consists of an

Ultrasound vendor Medison America has introduced a new accessory for its Voluson 530D 3-D ultrasound system, a breast probe that will allow clinicians to visualize lesions, tumors, and other abnormalities as 3-D shapes. The probe consists of an electronic broadband 5 to 10-MHz transducer with a center frequency of 7.5 MHz.

The probe can be used not only for breast cancer imaging, but also for thyroid and testicular cancer imaging, according to Dennis Wisher, director of ultrasound education. Since the probe is held in one position while it gathers 3-D volume data, it eliminates the need for sonographers to move a transducer over the patient’s skin, therefore reducing scan time and increasing accuracy, the company said. 3-D images generated by the probe can be rotated, and users can manipulate images with Medison’s ultrasound software, which includes niche, transparent, trapezoid, surface rendering, and live 3-D modes.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.